Pharmaceutical Continuous Manufacturing Market Size 2022-2027: Industry Share, Trends, Growth and Forecast

The latest research study "Pharmaceutical Continuous Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" by IMARC Group, finds that the global pharmaceutical continuous manufacturing market size reached US$ 1.05 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 2.24 Billion by 2027 exhibiting a growth rate (CAGR) of 12.70% during 2022-2027.

Covid-19 Impact:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Download free sample brochure: https://www.imarcgroup.com/pharmaceutical-continuous-manufacturing-market/requestsample

Industry Definition and Application:

Pharmaceutical continuous manufacturing represents an end-to-end medication production approach that enhances the consistency and quality of several novel drugs and vaccines with minimal capital investments. As compared to batch processing, it is easier to scale, operates in a flow, offers greater control to manufacturers, eliminates physical intervention, etc.

Pharmaceutical continuous manufacturing assists in minimizing the medicine formulation duration and risk of human errors, monitoring the production procedures, improving the product quality to harmonize with the regulatory guidelines, etc. Consequently, the technique is widely used by contract manufacturing organizations (CMOs) and pharmaceutical companies to develop active pharmaceutical ingredients (API) and medicines. Presently, it is commonly available in semi-continuous, integrated, and control types.

Pharmaceutical Continuous Manufacturing Market Trends and Drivers:

The escalating demand for effective medicine production systems to compose various effective biologics at a lower cost, owing to the growing prevalence of chronic diseases and the increasing drug shortages, is primarily driving the pharmaceutical continuous manufacturing market.

Additionally, the rising consumer health concerns, on account of the sudden outbreak of the COVID-19 pandemic, are augmenting the utilization of this approach to produce novel vaccines, which is further catalyzing the market growth. Besides this, the emerging trend of automation in the pharmaceutical manufacturing methodology is acting as another significant growth-inducing factor.

Moreover, extensive investments in R&D activities and easy availability of food and drug administration (FDA) approved medicines are anticipated to fuel the pharmaceutical continuous manufacturing market over the forecasted period.

Click here to view detailed information with table of content: https://www.imarcgroup.com/pharmaceutical-continuous-manufacturing-market

Report Segmentation:

The report has been segmented the market into following categories:

Breakup by Therapeutics Type:
• Large Molecules
• Small Molecules

Breakup by Formulation:
• Solid Formulation
• Liquid and Semi-solid Formulation

Breakup by Application:
• Final Drug Product Manufacturing
• API Manufacturing

Breakup by End User:
• Pharmaceutical Companies
• Contract Manufacturing Organizations
• Others

By Geography:
•North America (United States, Canada)
•Asia Pacific (China, Japan, India, South Korea, •Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, •Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

List of Major Key Players:
The major players in the market are Baker Perkins, Coperion GmbH (Hillenbrand Inc.), Eli Lilly and Company, GEA Group Aktiengesellschaft, Glatt GmbH, Korsch AG, Novartis AG, Siemens, SK biotek, Thermo Fisher Scientific Inc. and Viatris Inc.

Also, Read Latest Research Reports by IMARC Group:

Ultrasound Devices Market Report: https://www.imarcgroup.com/ultrasound-devices-market

Local Anesthesia Drugs Market Forecast: https://www.imarcgroup.com/local-anesthesia-drugs-market

Influenza Diagnostics Market Size: https://www.imarcgroup.com/influenza-diagnostics-market

Anesthesia and Respiratory Devices Market Size: https://www.imarcgroup.com/anesthesia-respiratory-devices-market

Smart Insulin Pens Market Report 2022-2027: https://www.imarcgroup.com/smart-insulin-pens-market

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.